Flow of Current | Learn with BYJU'S

Keytruda (Pembrolizumab) for Mesothelioma: FDA-Approved Drug

Keytruda Leads to Durable Response for Some People With Advanced Liver Cancer

Early free access to ‘miracle drug’ Keytruda blocked, cancer groups say news ‘gutting’

Let’s use Keytruda (pembrolizumab) as an example… it is an FDA-approved immunotherapy drug used to treat several cancers, including melanoma, lung, bladder, head and neck, breast, and colorectal cancers. Average cost: around $11,000–$13,000 per dose (given every 3–6 weeks) It’s a PD-1 checkpoint inhibitor that blocks the PD-1 receptor on immune cells, releasing the immune “brakes” so T-cells can attack cancer cells that hide from detection. 🤷🏼‍♀️Common side effects: fatigue, nausea, rash, join